Dihydroergotamine nasal spray.
Gijsman
H J
HJ
Ferrari
M D
MD
D000281:Administration, Intranasal; D015982:Bias; D018849:Controlled Clinical Trials as Topic; D004087:Dihydroergotamine / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D010147:Pain Measurement; D015203:Reproducibility of Results; D012107:Research Design
D004087:Dihydroergotamine